Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option?

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1080/14740338.2021.1887850

Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option?

Federica Tomao & Innocenza Palaia et al. · 2021-02-15

Links

DOI PubMed

Journal

Expert Opinion on Drug Safety

Authors

Federica Tomao, Giuseppe Caruso, Lucia Musacchio, Violante Di Donato, Maria Cristina Petrella, Monica Verrico, Silverio Tomao, Pierluigi Benedetti Panici, Ludovico Muzii, Innocenza Palaia